<DOC>
	<DOC>NCT00572910</DOC>
	<brief_summary>This is a study to evaluate the safety and immunogenicity of V710 with and without Merck Aluminum Adjuvant (MAA) in adult participants with end-stage kidney disease who are on hemodialysis.</brief_summary>
	<brief_title>A Study to Evaluate the Safety and Immunogenicity of V710 in Adults With Kidney Disease on Hemodialysis (V710-005)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Staphylococcal Infections</mesh_term>
	<criteria>Diagnosed with end stage kidney disease and is on hemodialysis Female patients who are able to have children must have a negative urine pregnancy tests Developed a serious infection within the past 12 months; allergy to the components of the vaccine Has been vaccinated with a live virus within the past 30 days or are scheduled to be vaccinated with a live virus in the next 60 days Received V710 vaccine before</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>